For instance, research has demonstrated the upregulation of RAMP1 in breast invasive carcinoma (BRCA), prostate adenocarcinoma (PRAD), and liver hepatocellular carcinoma (LIHC). Here, RAMP1 is linked to invasive breast carcinoma.